Genex ApS: Financial statements 2024
CVR: 42881112
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Genex ApS (CVR 42881112) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -1,500 and a net result of DKK -1,434 compared with DKK -5,971 the year before. Equity in the 2024 report amounted to DKK 23,213. The solvency ratio was 88.6%.
- Gross Profit
- DKK -1,500
- Profit/Loss
- DKK -1,434
- Equity
- DKK 23,213
- Total Assets
- DKK 26,186
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -2 t. | -1 t. | 23 t. | - |
| 2023 | - | -6 t. | -6 t. | 25 t. | - |
| 2022 | - | -9 t. | -9 t. | 31 t. | - |
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Genex ApS has published its annual report for 2023. Gross profit came to DKK -5,987, and the net result was DKK -5,971.
About Genex ApS
Genex ApS is a Danish company of the type Anpartsselskab based in Holbæk, founded in 2021. The company is registered under the industry Traditionelle, komplementære og alternative behandlingsformer. The management consists of Lone Majbritt Christiansen. The company is owned by Lone Majbritt Christiansen. In 2025, the company reported a gross profit of DKK -1,500 and a net result of DKK -1,500 compared with DKK -1,434 the year before. Equity in the 2025 report amounted to DKK 21,713.